Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MUSTANG BIO, INC.MBIO · Entity 8350 | SVP, Fin. & Corp. Controller | December 08, 2021 | December 16, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MUSTANG BIO, INC.
Report date December 08, 2021 · Filed December 16, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| COMMON STOCKSEC Table I · non-derivative | Direct | 144,729 |
Last balance in matching sequence
After 2021-12-14 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2021-12-08 · Grant · Acquired 22,500 · Balance 149,103 F1: Each restricted stock unit represents the right to receive one share of Common Stock of Mustang Bio, Inc. The restricted stock units will vest at different times over a period of 4 years. F4: Includes restricted share units, which vest over various time periods. Row 2 · 2021-12-14 · Sale · Disposed 4,374 · Balance 144,729 F2: 4,374 shares were sold in connection with the vesting of 13,750 shares on December 4, 2021, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Achenbach's tax withholding obligations. Mr. Achenbach had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock. F3: Represents the weighted average sales price. F4: Includes restricted share units, which vest over various time periods. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents the right to receive one share of Common Stock of Mustang Bio, Inc. The restricted stock units will vest at different times over a period of 4 years.
F2: 4,374 shares were sold in connection with the vesting of 13,750 shares on December 4, 2021, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Achenbach's tax withholding obligations. Mr. Achenbach had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
F3: Represents the weighted average sales price.
F4: Includes restricted share units, which vest over various time periods.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 14, 2021 Filed Dec 16, 2021 21:30 UTC | MUSTANG BIO, INC. MBIO · Entity 8350 | SaleCOMMON STOCK | 4,374 | $1.83 | $8,004.42 |
DisclosureSEC source: 0001104659-21-150544 · tm2135704d1_4.xml · nonDerivative · entry 2 Achenbach Brian · CIK 0001760132 · SVP, Fin. & Corp. Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,729 F2 · kind: 4,374 shares were sold in connection with the vesting of 13,750 shares on December 4, 2021, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Achenbach's tax withholding obligations. Mr. Achenbach had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock. F3 · price: Represents the weighted average sales price. F4 · balance_after: Includes restricted share units, which vest over various time periods. Read SEC document |
| December 08, 2021 Filed Dec 16, 2021 21:30 UTC | MUSTANG BIO, INC. MBIO · Entity 8350 | GrantCOMMON STOCK | 22,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-150544 · tm2135704d1_4.xml · nonDerivative · entry 1 Achenbach Brian · CIK 0001760132 · SVP, Fin. & Corp. Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,103 F1 · shares: Each restricted stock unit represents the right to receive one share of Common Stock of Mustang Bio, Inc. The restricted stock units will vest at different times over a period of 4 years. F4 · balance_after: Includes restricted share units, which vest over various time periods. Read SEC document |
| October 12, 2021 Filed Oct 21, 2021 20:32 UTC | MUSTANG BIO, INC. MBIO · Entity 8350 | SaleCOMMON STOCK | 4,450 | $2.28 | $10,146.00 |
DisclosureSEC source: 0001104659-21-128486 · tm2130779-1_4seq1.xml · nonDerivative · entry 1 Achenbach Brian · CIK 0001760132 · SVP, Fin. & Corp. Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,603 F1 · kind: 4,450 shares were sold in connection with the vesting of 14,688 shares on October 10, 2021, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Achenbach's tax withholding obligations. Mr. Achenbach had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock. F2 · price: Represents the weighted average sales price. F3 · balance_after: Includes restricted share units, which vest over various time periods. Read SEC document |
| April 09, 2021 Filed Apr 16, 2021 20:32 UTC | MUSTANG BIO, INC. MBIO · Entity 8350 | SaleCOMMON STOCK | 2,423 | $3.36 | $8,141.28 |
DisclosureSEC source: 0001104659-21-051419 · tm2113178-1_4seq1.xml · nonDerivative · entry 6 Achenbach Brian · CIK 0001760132 · SVP, Fin. & Corp. Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,053 F6 · kind: 2,423 shares were sold in connection with the vesting of 8,750 shares on March 27, 2021, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Achenbach's tax withholding obligations. Mr. Achenbach had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock. F7 · price: Represents the weighted average sales price. F8 · balance_after: Includes restricted share units, which vest over various time periods. Read SEC document |
| December 15, 2020 Filed Mar 15, 2021 10:28 UTC | MUSTANG BIO, INC. MBIO · Entity 8350 | GrantCommon Stock | 22,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-035850 · tm219639-3_4.xml · nonDerivative · entry 1 Achenbach Brian · CIK 0001760132 · SVP, Fin. & Corp. Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,774 F1 · shares: Each restricted stock unit represents the right to receive one share of Common Stock of Mustang Bio, Inc.. F2 · balance_after: Includes restricted stock units, which vest over various time periods. Read SEC document |
| December 08, 2020 Filed Apr 16, 2021 20:32 UTC | MUSTANG BIO, INC. MBIO · Entity 8350 | SaleCOMMON STOCK | 5,185 | $3.03 | $15,710.55 |
DisclosureSEC source: 0001104659-21-051419 · tm2113178-1_4seq1.xml · nonDerivative · entry 5 Achenbach Brian · CIK 0001760132 · SVP, Fin. & Corp. Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,476 F5 · kind: 5,185 shares were sold in connection with the vesting of 13,750 shares on December 4, 2020, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Achenbach's tax withholding obligations. Mr. Achenbach had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock. F7 · price: Represents the weighted average sales price. F8 · balance_after: Includes restricted share units, which vest over various time periods. Read SEC document |
| October 21, 2020 Filed Apr 16, 2021 20:32 UTC | MUSTANG BIO, INC. MBIO · Entity 8350 | SaleCOMMON STOCK | 3,056 | $2.97 | $9,076.32 |
DisclosureSEC source: 0001104659-21-051419 · tm2113178-1_4seq1.xml · nonDerivative · entry 4 Achenbach Brian · CIK 0001760132 · SVP, Fin. & Corp. Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,661 F4 · kind: 3,056 shares were sold in connection with the vesting of 9,063 shares on October 10, 2020, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Achenbach's tax withholding obligations. Mr. Achenbach had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock. F7 · price: Represents the weighted average sales price. F8 · balance_after: Includes restricted share units, which vest over various time periods. Read SEC document |
| May 22, 2020 Filed Apr 16, 2021 20:32 UTC | MUSTANG BIO, INC. MBIO · Entity 8350 | SaleCOMMON STOCK | 880 | $3.04 | $2,675.20 |
DisclosureSEC source: 0001104659-21-051419 · tm2113178-1_4seq1.xml · nonDerivative · entry 3 Achenbach Brian · CIK 0001760132 · SVP, Fin. & Corp. Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,717 F3 · kind: 880 shares were sold in connection with the vesting of 3,438 shares on March 26, 2020, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Achenbach's tax withholding obligations. Mr. Achenbach had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock. F7 · price: Represents the weighted average sales price. F8 · balance_after: Includes restricted share units, which vest over various time periods. Read SEC document |
| March 31, 2020 Filed Apr 16, 2021 20:32 UTC | MUSTANG BIO, INC. MBIO · Entity 8350 | SaleCOMMON STOCK | 3,033 | $2.64 | $8,007.12 |
DisclosureSEC source: 0001104659-21-051419 · tm2113178-1_4seq1.xml · nonDerivative · entry 2 Achenbach Brian · CIK 0001760132 · SVP, Fin. & Corp. Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,597 F2 · kind: 3,033 shares were sold in connection with the vesting of 8,750 shares on March 27, 2020, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Achenbach's tax withholding obligations. Mr. Achenbach had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock. F7 · price: Represents the weighted average sales price. F8 · balance_after: Includes restricted share units, which vest over various time periods. Read SEC document |
| March 26, 2020 Filed Apr 29, 2020 12:48 UTC | MUSTANG BIO, INC. MBIO · Entity 8350 | GrantCommon Stock | 36,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-052883 · tm2018004-1_form4.xml · nonDerivative · entry 2 Achenbach Brian · CIK 0001760132 · SVP, Fin. & Corp. Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,274 F2 · shares: Each restricted stock unit represents the right to receive one share of Common Stock of Mustang Bio, Inc. F3 · balance_after: Includes restricted share units, which vest over various time periods. Read SEC document |
| March 05, 2020 Filed Apr 29, 2020 12:48 UTC | MUSTANG BIO, INC. MBIO · Entity 8350 | GrantCommon Stock | 524 | $2.48 | $1,299.52 |
DisclosureSEC source: 0001104659-20-052883 · tm2018004-1_form4.xml · nonDerivative · entry 1 Achenbach Brian · CIK 0001760132 · SVP, Fin. & Corp. Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,024 F1 · shares: These shares were acquired under the Mustang Bio, Inc. Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on September 1, 2019 and ending on February 29, 2020 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's ordinary shares on February 28, 2020 (the last trading day of the offering period). F3 · balance_after: Includes restricted share units, which vest over various time periods. Read SEC document |
| December 06, 2019 Filed Apr 16, 2021 20:32 UTC | MUSTANG BIO, INC. MBIO · Entity 8350 | SaleCOMMON STOCK | 6,144 | $3.69 | $22,671.36 |
DisclosureSEC source: 0001104659-21-051419 · tm2113178-1_4seq1.xml · nonDerivative · entry 1 Achenbach Brian · CIK 0001760132 · SVP, Fin. & Corp. Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,630 F1 · kind: 6,144 shares were sold in connection with the vesting of 13,750 shares on December 4, 2019, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Achenbach's tax withholding obligations. Mr. Achenbach had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock. F7 · price: Represents the weighted average sales price. F8 · balance_after: Includes restricted share units, which vest over various time periods. Read SEC document |
| April 16, 2019 Filed Jan 17, 2020 22:45 UTC | MUSTANG BIO, INC. MBIO · Entity 8350 | GrantCommon Stock | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-005212 · tm203350d5_form4.xml · nonDerivative · entry 1 Achenbach Brian · CIK 0001760132 · SVP, Fin. & Corp. Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,500 F1 · balance_after: 90,000 shares are restricted Common Stock which vest over various time periods. Read SEC document |
| November 20, 2018 Filed Dec 3, 2018 17:47 UTC | MUSTANG BIO, INC. MBIO · Entity 8350 | PurchaseCOMMON STOCK | 500 | $3.87 | $1,937.10 |
DisclosureSEC source: 0001144204-18-062799 · tv508274_form4.xml · nonDerivative · entry 4 Achenbach Brian · CIK 0001760132 · VP, Fin. & Corp. Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,500 F1 · balance_after: 55,000 shares are restricted Common Stock which vest over various time periods. Read SEC document |
| November 19, 2018 Filed Dec 3, 2018 17:47 UTC | MUSTANG BIO, INC. MBIO · Entity 8350 | PurchaseCOMMON STOCK | 1,000 | $4.25 | $4,250.00 |
DisclosureSEC source: 0001144204-18-062799 · tv508274_form4.xml · nonDerivative · entry 3 Achenbach Brian · CIK 0001760132 · VP, Fin. & Corp. Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,000 F2 · price: Reflects the weighted average purchase price of multiple same-way open market purchase transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the purchase transactions on November 16, 2018 was $4.15 to $4.3792, and the range of prices for the purchase transactions on November 19, 2018 was $4.15 to $4.35. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price. F1 · balance_after: 55,000 shares are restricted Common Stock which vest over various time periods. Read SEC document |
| November 16, 2018 Filed Dec 3, 2018 17:47 UTC | MUSTANG BIO, INC. MBIO · Entity 8350 | PurchaseCOMMON STOCK | 1,000 | $4.31 | $4,310.00 |
DisclosureSEC source: 0001144204-18-062799 · tv508274_form4.xml · nonDerivative · entry 2 Achenbach Brian · CIK 0001760132 · VP, Fin. & Corp. Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,000 F2 · price: Reflects the weighted average purchase price of multiple same-way open market purchase transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the purchase transactions on November 16, 2018 was $4.15 to $4.3792, and the range of prices for the purchase transactions on November 19, 2018 was $4.15 to $4.35. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price. F1 · balance_after: 55,000 shares are restricted Common Stock which vest over various time periods. Read SEC document |
| February 02, 2018 Filed Dec 3, 2018 17:47 UTC | MUSTANG BIO, INC. MBIO · Entity 8350 | GrantCOMMON STOCK | 55,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-062799 · tv508274_form4.xml · nonDerivative · entry 1 Achenbach Brian · CIK 0001760132 · VP, Fin. & Corp. Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 F1 · balance_after: 55,000 shares are restricted Common Stock which vest over various time periods. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.